Jérémie Calais

机构：University of California, Los Angeles, Molecular Theranostics (United States) · ORCID：0000-0002-8839-4379

发表论文 404 篇 · 总被引 11586 次 · h-index 52

代表论文

• Additional file 1 of Influence of increased injected activities up 9.0 GBq [177Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys (2026 · Figshare)
• Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study (2026 · medRxiv)
• Additional file 1 of Influence of increased injected activities up 9.0 GBq [177Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys (2026 · Figshare)
• PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer (2026 · European Urology Focus)
• Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial. (2026 · Open Access CRIS of the University of Bern)
• Intratumoral dose heterogeneity promotes adaptive anti-tumor immunity and predicts clinical response to radiopharmaceutical therapy (2026 · bioRxiv (Cold Spring Harbor Laboratory))